Park Do Hyun, Lee Sang Soo, Moon Jong Ho, Choi Hyun Jong, Cha Sang-Woo, Kim Jong Hyeok, Seo Dong-Wan, Lee Sung-Koo, Park Sang-Heum, Lee Moon-Sung, Kim Sun-Joo, Kim Myung-Hwan
Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Gastrointest Endosc. 2009 Jun;69(7):1357-60. doi: 10.1016/j.gie.2008.12.250.
Endoscopic management of malignant hilar biliary strictures is difficult even for an experienced endoscopist. Moreover, endoscopic placement of bilateral metal stents is considered very difficult and complicated.
We explored the feasibility and efficacy of the placement of a newly designed metal stent for an endoscopic bilateral stent-in-stent procedure for the management of malignant hilar biliary strictures.
Multicenter prospective feasibility study.
Five academic tertiary referral centers.
Thirty-five patients with malignant hilar biliary strictures of Bismuth type II or higher were enrolled.
Bilateral stent placement by an endoscopic stent-in-stent procedure.
Technical success, functional success, early and late complications, stent patency.
The overall technical success rate of the newly designed metal stent was 94.3% (33/35). The success rate of the stent-in-stent procedure in a single session was 82% (27/33) per protocol and 77% (27/35) as intent to treat. In cases in which the initial stent-in-stent procedure failed, patients underwent the endoscopic stent-in-stent procedure for contralateral stent placement at 2 days (6%, 2/33) or 4 days (12%, 4/33) after the initial stent placement. There was no percutaneous insertion of a contralateral stent in these patients. There was no stent-related early or late complication in any enrolled patient. Functional success was 100% (33/33). Reintervention because of stent malfunction was 6% (2/33). These 2 patients showed sludge formation in the stent. During follow-up, there was no stent tumor ingrowth or overgrowth in the placed stent in any enrolled patient. According to the Kaplan-Meier analysis, median survival and stent patency were 180 days and 150 days, respectively.
An uncontrolled feasibility study with a small patient population and a limited follow-up period.
The newly designed metal stent for the endoscopic bilateral stent-in-stent procedure may be feasible and effective for malignant hilar biliary strictures.
即使对于经验丰富的内镜医师而言,恶性肝门部胆管狭窄的内镜治疗也颇具难度。此外,内镜下双侧金属支架置入被认为非常困难且复杂。
我们探讨了一种新设计的金属支架在内镜下双侧支架套叠术治疗恶性肝门部胆管狭窄中的可行性和疗效。
多中心前瞻性可行性研究。
五家学术性三级转诊中心。
纳入35例Bismuth II型或更高分型的恶性肝门部胆管狭窄患者。
通过内镜支架套叠术进行双侧支架置入。
技术成功率、功能成功率、早期和晚期并发症、支架通畅情况。
新设计的金属支架总体技术成功率为94.3%(33/35)。按照方案,单次支架套叠术的成功率为82%(27/33),意向性治疗成功率为77%(27/35)。在初始支架套叠术失败的病例中,患者在初次支架置入后2天(6%,2/33)或4天(12%,4/33)接受了对侧支架置入的内镜支架套叠术。这些患者均未进行对侧支架的经皮插入。所有纳入患者均未出现与支架相关的早期或晚期并发症。功能成功率为100%(33/33)。因支架功能障碍而再次干预的比例为6%(2/33)。这2例患者的支架内出现了胆泥形成。随访期间,所有纳入患者置入的支架均未出现肿瘤长入或过度生长。根据Kaplan-Meier分析,中位生存期和支架通畅时间分别为180天和150天。
一项未设对照的可行性研究,患者数量少且随访期有限。
新设计的用于内镜双侧支架套叠术的金属支架在治疗恶性肝门部胆管狭窄方面可能是可行且有效的。